GYNEMAJE
0820.156.873 · rovalta.com · 22/09/2026
GYNEMAJE
Overview
What does GYNEMAJE do?
GYNEMAJE is a Private company with limited liability incorporated in 2009. Its main activity is: Specialist medical practice activities. Its registered office is in Etterbeek. It employs on average 1,3 ETP workers (FTE).
1040 Etterbeek · BruxellesSee on map
Trend over 15 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||
| Gross margin | 322,4 k € | +25.2% | 257,5 k € | +30.6% | 197,1 k € | -29.7% | 280,5 k € | +38.6% | 202,3 k € | +48.7% | 136 k € | -35.4% | 210,5 k € | +3.9% | 202,6 k € | +35.2% | 149,8 k € | -44.3% | 269 k € | +47.2% | 182,8 k € | -18.2% | 223,4 k € | -3.8% | 232,3 k € | +2.5% | 226,6 k € | -14.9% | 266,4 k € |
| EBITDA | 237,2 k € | +32.7% | 178,7 k € | +33.7% | 133,7 k € | -42.5% | 232,3 k € | +41.9% | 163,8 k € | +67.2% | 98 k € | -46.2% | 182,1 k € | -9.0% | 200,1 k € | +40.3% | 142,7 k € | -45.0% | 259,2 k € | +47.9% | 175,3 k € | -17.6% | 212,8 k € | -7.0% | 228,9 k € | +1.7% | 225 k € | -14.8% | 264,2 k € |
| Operating result | 205 k € | +31.0% | 156,5 k € | +37.9% | 113,5 k € | -46.4% | 211,7 k € | +42.1% | 148,9 k € | +81.3% | 82,1 k € | -45.7% | 151,3 k € | +9.3% | 138,4 k € | +168% | 51,6 k € | -59.7% | 128,2 k € | +484% | 22 k € | -65.5% | 63,6 k € | -41.3% | 108,4 k € | -18.7% | 133,3 k € | -29.8% | 189,9 k € |
| Net result | 145,1 k € | +27.2% | 114,1 k € | +43.4% | 79,5 k € | -43.1% | 139,9 k € | +41.0% | 99,2 k € | +86.8% | 53,1 k € | -45.4% | 97,2 k € | -5.8% | 103,2 k € | +149% | 41,5 k € | -61.7% | 108,2 k € | +533% | 17,1 k € | -62.0% | 45 k € | -41.8% | 77,3 k € | -13.1% | 88,9 k € | -29.0% | 125,2 k € |
| Balance sheet | |||||||||||||||||||||||||||||
| Equity | 706,6 k € | +19.7% | 590,6 k € | +12.2% | 526,5 k € | +0.1% | 526 k € | +10.5% | 476,1 k € | +6.2% | 448,4 k € | +0.7% | 445,3 k € | +11.9% | 398,1 k € | +15.4% | 344,9 k € | +13.7% | 303,4 k € | +10.2% | 275,2 k € | +6.6% | 258,2 k € | +21.1% | 213,2 k € | +56.9% | 135,9 k € | -7.5% | 147 k € |
| Total assets | 884,6 k € | +12.8% | 783,9 k € | +11.4% | 704 k € | -9.9% | 781,4 k € | +16.6% | 670 k € | +20.5% | 556,1 k € | +0.0% | 556,1 k € | +7.0% | 519,6 k € | +2.0% | 509,5 k € | -24.7% | 676,8 k € | +103% | 334,2 k € | -17.1% | 403 k € | -7.0% | 433,1 k € | +8.2% | 400,2 k € | +23.0% | 325,4 k € |
| Cash | 60,6 k € | +10671% | 562,4 € | -99.2% | 70,1 k € | -51.7% | 145,1 k € | +223% | 44,9 k € | +52.0% | 29,6 k € | -28.7% | 41,4 k € | -11.6% | 46,9 k € | +869% | 4,8 k € | -93.7% | 76,7 k € | +123% | 34,5 k € | -17.6% | 41,8 k € | -62.1% | 110,4 k € | -6.3% | 117,8 k € | +1.3% | 116,3 k € |
| Debts | 178 k € | -7.9% | 193,3 k € | +8.9% | 177,5 k € | -30.5% | 255,4 k € | +31.7% | 193,9 k € | +80.1% | 107,6 k € | -2.8% | 110,7 k € | -8.8% | 121,5 k € | -26.2% | 164,6 k € | -55.9% | 373,4 k € | +533% | 59 k € | -59.3% | 144,8 k € | -34.1% | 219,8 k € | -16.8% | 264,1 k € | +49.9% | 176,1 k € |
| Other | |||||||||||||||||||||||||||||
| Workforce | 1,3 ETP | +8.3% | 1,2 ETP | -7.7% | 1,3 ETP | +44.4% | 0,9 ETP | +80.0% | 0,5 ETP | -28.6% | 0,7 ETP | – | – | 0,4 ETP | +100% | 0,2 ETP | -50.0% | 0,4 ETP | – | – | – | – | |||||||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2024 · 1 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
| 0819.501.827 | |
PSYLANTS● Active | 1028.745.772 |
| 0412.572.474 |
Financials
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/10/2025 | 31/10/2024 | 29/11/2023 | 28/10/2022 | 11/10/2021 | 06/11/2020 |
| General meeting | 17/05/2025 | 18/05/2024 | 20/05/2023 | 21/05/2022 | 15/05/2021 | 16/05/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
16 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 17/05/2025 | 07/10/2025 | French | |
| Abridged model | 31/12/2023 | 18/05/2024 | 31/10/2024 | French | |
| Abridged model | 31/12/2022 | 20/05/2023 | 29/11/2023 | French | |
| Abridged model | 31/12/2021 | 21/05/2022 | 28/10/2022 | French | |
| Abridged model | 31/12/2020 | 15/05/2021 | 11/10/2021 | French | |
| Abridged model | 31/12/2019 | 16/05/2020 | 06/11/2020 | French | |
| Abridged model | 31/12/2018 | 18/05/2019 | 29/08/2019 | French | |
| Abridged modelCorrection | 31/12/2017 | 19/05/2018 | 10/09/2018 | French | |
| Abridged model | 31/12/2017 | 19/05/2018 | 29/08/2018 | French | |
| Abridged model | 31/12/2016 | 20/05/2017 | 27/09/2017 | French | |
| Abridged model | 31/12/2015 | 21/05/2016 | 26/08/2016 | French | |
| Abridged model | 31/12/2014 | 16/05/2015 | 30/09/2015 | French | |
| Abridged model | 31/12/2013 | 17/05/2014 | 30/09/2014 | French | |
| Abridged model | 31/12/2012 | 18/05/2013 | 17/07/2013 | French | |
| Abridged model | 31/12/2011 | 19/05/2012 | 11/07/2012 | French | |
| Abridged model | 31/12/2010 | 21/05/2011 | 29/07/2011 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2024 · 1 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024145,1 k €↑
- 2023Annual accounts 2023114,1 k €↑
- 2022Annual accounts 202279,5 k €↓
- 2021Annual accounts 2021139,9 k €↑
- 2020Annual accounts 202099,2 k €↑
- 2019Annual accounts 201953,1 k €↓
- 2018Annual accounts 201897,2 k €↓
- 2017Annual accounts 2017103,2 k €↑
- 2016Annual accounts 201641,5 k €↓
- 2015Annual accounts 2015108,2 k €↑
- 2014Annual accounts 201417,1 k €↓
- 2013Annual accounts 201345 k €↓
- 2012Annual accounts 201277,3 k €↓
- 2011Annual accounts 201188,9 k €↓
- 2010Annual accounts 2010125,2 k €
- 29/10/2009IncorporationPrivate company with limited liability